OrganoTherapeutics SARL
PrivateLast Round
VC Round
Jul 1, 2023
Total Funding Raised
$789,000
Company Overview
OrganoTherapeutics SARL operates in Healthcare & Life Sciences and is based in Esch-sur-Alzette. Its latest recorded funding round was a VC Round in July 2023.
OrganoTherapeutics SARL is a biotechnology company that develops human patient-specific midbrain organoids for the discovery and development of drug candidates targeting Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganoTherapeutics SARL Comparables
Compare OrganoTherapeutics SARL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vivodyne | 84% | |
| Herophilus | 82% | |
| Brain Organoid Therapeutics | 82% |
For institutional investors. Book with your work email.
OrganoTherapeutics SARL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 1, 2023 | ||||
| Grant | Mar 1, 2023 | ||||
| Accelerator | Oct 15, 2020 |
For institutional investors. Book with your work email.
OrganoTherapeutics SARL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Fit 4 Start | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2026
Monthly visitors increased 2190% MoM, reaching 1.3K.
- Jul 1, 2023
Completed a VC Round funding round.
For institutional investors. Book with your work email.
OrganoTherapeutics SARL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OrganoTherapeutics SARL's valuation, stock price, and market status.
Is OrganoTherapeutics SARL a public or private company?
OrganoTherapeutics SARL is a private company.
What is the current stock price of OrganoTherapeutics SARL?
OrganoTherapeutics SARL is a private company, so its shares have no public market price. Caplight tracks OrganoTherapeutics SARL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OrganoTherapeutics SARL worth (valuation)?
Valuation information for OrganoTherapeutics SARL is not publicly available.
Can I buy OrganoTherapeutics SARL stock?
OrganoTherapeutics SARL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OrganoTherapeutics SARL's last funding round?
OrganoTherapeutics SARL's most recent funding round was VC Round on July 1, 2023.
Who are the main investors in OrganoTherapeutics SARL?
Key investors in OrganoTherapeutics SARL include European Innovation Council Fund, Fit 4 Start.
Will OrganoTherapeutics SARL IPO soon?
No public IPO plans have been announced for OrganoTherapeutics SARL.
How can I track OrganoTherapeutics SARL secondary market activity?
Caplight tracks bids, offers, and trades in OrganoTherapeutics SARL's shares on secondary markets.